This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A National Survey

Paul R. Bergstresser, MD; Susan H. Schreiber; Gerald D. Weinstein, MD

Arch Dermatol. 1976;112(7):977-981.

Abstract
• A questionnaire that was mailed to 510 randomly selected dermatologists in the United States surveyed their use of three systemic chemotherapeutic agents for the treatment of psoriasis during the two-year period of 1973 to 1974. Methotrexate was used by 52% of the surveyed dermatologists, while hydroxyurea and azaribine were used by 10% and 2%, respectively. Seventy-five percent of the dermatologists who used methotrexate treated ten or fewer psoriatic patients with this drug. Multiple dose therapy with methotrexate divided over a period of 36 hours each week was the preferred schedule of 66% of the dermatologists. Liver biopsy specimens and creatinine clearance tests were obtained for only 17% and 35% of patients, respectively, prior to initiating methotrexate therapy. The estimated number of dermatologisttreated psoriatics nationwide receiving methotrexate is 25,000.

(Arch Dermatol 112:977-981, 1976)

Author Affiliations
From the Department of Dermatology (Drs Bergstresser and Weinstein and Ms Schreiber), University of Miami School of Medicine and the Miami Veterans Administration Hospital (Dr Bergstresser), Miami, Fla.

Footnotes
Accepted for publication Oct 28, 1975.

Read in part before the American Dermatological Association, Palm Beach, Fla, March 19, 1975.

Reprint requests to Department of Dermatology, University of Miami School of Medicine, Box 520875, Biscayne Annex, Miami, FL 33152 (Dr Bergstresser).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methotrexate-Induced Cirrhosis Requiring Liver Transplantation in Three Patients With Psoriasis: A Word of Caution in Light of the Expanding Use of This 'Steroid-Sparing' Agent
Gilbert et al.
Arch Intern Med 1990;150:889-891.
ABSTRACT  

Psoriasis Practices
Baughman
Arch Dermatol 1987;123:1299-1300.
ABSTRACT  

The Treatment of Severe Psoriasis: A National Survey
Peckham et al.
Arch Dermatol 1987;123:1303-1307.
ABSTRACT  

Commentary: Three Decades of Folic Acid Antagonists in Dermatology
Weinstein
Arch Dermatol 1983;119:525-527.
ABSTRACT  

Methotrexate Hepatotoxicity in Psoriasis: Consideration of Liver Biopsies at Regular Intervals
Robinson et al.
Arch Dermatol 1980;116:413-415.
ABSTRACT  

Drugs Five Years Later: Methotrexate
WEINSTEIN
ANN INTERN MED 1977;86:199-204.
ABSTRACT